Glucose-6-phosphate dehydrogenase deficiency accelerates arterial aging in diabetes

Acta Diabetol. 2024 Jan;61(1):127-130. doi: 10.1007/s00592-023-02118-8. Epub 2023 Sep 23.

Abstract

Aims: High glucose levels and Glucose-6-Phosphate Dehydrogenase deficiency (G6PDd) have both tissue inflammatory effects. Here we determined whether G6PDd accelerates arterial aging (information linked stiffening) in diabetes.

Methods: Plasma glucose, interleukin 6 (IL6), and arterial stiffness (indexed as carotid-femoral Pulse Wave Velocity, PWV) and red blood cell G6PD activity were assessed in a large (4448) Sardinian population.

Results: Although high plasma glucose in diabetics, did not differ by G6DP status (178.2 ± 55.1 vs 169.0 ± 50.1 mg/dl) in G6DPd versus non-G6PDd subjects, respectively, IL6, and PWV (adjusted for age and glucose) were significantly increased in G6PDd vs non-G6PDd subjects (PWV, 8.0 ± 0.4 vs 7.2 ± 0.2 m/sec) and (IL6, 6.9 ± 5.0 vs 4.2 ± 3.0 pg/ml). In non-diabetics, neither fasting plasma glucose, nor IL6, nor PWV were impacted by G6PDd.

Conclusion: G6PDd in diabetics is associated with increased inflammatory markers and accelerated arterial aging.

Keywords: Aging; Arterial stiffness; Diabetes; Glucose 5 phosphate dehydrogenase; Interleukin 6; Pulse wave velocity.

MeSH terms

  • Aging
  • Blood Glucose
  • Diabetes Mellitus* / epidemiology
  • Glucosephosphate Dehydrogenase Deficiency* / epidemiology
  • Humans
  • Interleukin-6
  • Pulse Wave Analysis
  • Vascular Stiffness*

Substances

  • Blood Glucose
  • Interleukin-6
  • G6PD protein, human